Meridian Investment Counsel Inc. Pfizer Inc Transaction History

Meridian Investment Counsel Inc.

$334 Million
Q1 2025

A detailed history of Meridian Investment Counsel Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Meridian Investment Counsel Inc. holds 69,874 shares of PFE stock, worth $1.65 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

69,874

Previous 65,157 7.24%

Holding current value

$1.65 Million

Previous $1.73 Million 2.43%

% of portfolio

0.53%

Previous 0.52%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 29, 2025	BUY	$25.01 - $27.13 $117,972 - $127,972	4,717 Added 7.24%	69,874 $1.77 Million
Q4 2024 Feb 12, 2025	BUY	$24.8 - $30.19 $52,997 - $64,516	2,137 Added 3.39%	65,157 $1.73 Million
Q3 2024 Nov 06, 2024	SELL	$27.7 - $31.39 $52,380 - $59,358	-1,891 Reduced 2.91%	63,020 $1.82 Million
Q2 2024 Jul 19, 2024	BUY	$25.26 - $29.6 $10,104 - $11,840	400 Added 0.62%	64,911 $1.82 Million
Q1 2024 May 13, 2024	SELL	$25.89 - $29.73 $22,446 - $25,775	-867 Reduced 1.33%	64,511 $1.79 Million
Q4 2023 Feb 09, 2024	SELL	$26.13 - $33.94 $1,698 - $2,206	-65 Reduced 0.1%	65,378 $1.88 Million
Q3 2023 Nov 03, 2023	SELL	$32.09 - $37.51 $51,344 - $60,016	-1,600 Reduced 2.39%	65,443 $2.17 Million
Q2 2023 Aug 09, 2023	SELL	$36.12 - $41.79 $36,120 - $41,790	-1,000 Reduced 1.47%	67,043 $2.46 Million
Q1 2023 May 05, 2023	SELL	$39.39 - $51.28 $3,545 - $4,615	-90 Reduced 0.13%	68,043 $2.78 Million
Q4 2022 Feb 06, 2023	SELL	$41.75 - $54.5 $55,819 - $72,866	-1,337 Reduced 1.92%	68,133 $3.49 Million
Q3 2022 Nov 08, 2022	SELL	$43.76 - $53.42 $146,814 - $179,224	-3,355 Reduced 4.61%	69,470 $3.04 Million
Q2 2022 Aug 11, 2022	SELL	$46.53 - $55.17 $60,489 - $71,721	-1,300 Reduced 1.75%	72,825 $3.82 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $44,542 - $66,027	-1,078 Reduced 1.43%	74,125 $4.38 Million
Q3 2021 Oct 27, 2021	SELL	$39.25 - $50.42 $5,887 - $7,563	-150 Reduced 0.2%	75,203 $3.23 Million
Q2 2021 Jul 23, 2021	BUY	$35.91 - $40.68 $53,864 - $61,020	1,500 Added 2.03%	75,353 $2.95 Million
Q1 2021 May 03, 2021	BUY	$33.49 - $37.77 $703 - $793	21 Added 0.03%	73,853 $2.68 Million
Q4 2020 Feb 03, 2021	BUY	$33.47 - $42.56 $45,887 - $58,349	1,371 Added 1.89%	73,832 $2.72 Million
Q3 2020 Oct 23, 2020	BUY	$31.75 - $37.25 $40,386 - $47,382	1,272 Added 1.79%	72,461 $2.66 Million
Q2 2020 Aug 05, 2020	BUY	$30.12 - $36.54 $9,698 - $11,765	322 Added 0.45%	71,189 $2.33 Million
Q1 2020 Apr 30, 2020	BUY	$27.03 - $38.62 $16,461 - $23,519	609 Added 0.87%	70,867 $2.31 Million
Q4 2019 Feb 06, 2020	BUY	$32.92 - $37.36 $327,718 - $371,918	9,955 Added 16.51%	70,258 $2.75 Million
Q3 2019 Oct 25, 2019	BUY	$32.49 - $42.13 $682 - $884	21 Added 0.03%	60,303 $2.17 Million
Q2 2019 Aug 13, 2019	SELL	$36.98 - $41.52 $21,929 - $24,621	-593 Reduced 0.97%	60,282 $2.61 Million
Q1 2019 May 06, 2019	BUY	$37.5 - $41.2 $637 - $700	17 Added 0.03%	60,875 $2.59 Million
Q4 2018 Feb 13, 2019	SELL	$38.47 - $43.86 $25,390 - $28,947	-660 Reduced 1.07%	60,858 $2.66 Million
Q3 2018 Nov 05, 2018	BUY	$34.47 - $41.81 $551 - $668	16 Added 0.03%	61,518 $2.71 Million
Q2 2018 Aug 08, 2018	SELL	$32.98 - $35.16 $4,320 - $4,605	-131 Reduced 0.21%	61,502 $2.23 Million
Q1 2018 May 14, 2018	SELL	$31.91 - $37.02 $5,743 - $6,663	-180 Reduced 0.29%	61,633 $2.19 Million
Q4 2017 Feb 13, 2018	SELL	$33.26 - $35.29 $6,086 - $6,458	-183 Reduced 0.3%	61,813 $2.24 Million
Q3 2017 Nov 08, 2017	SELL	$31.0 - $34.15 $11,811 - $13,011	-381 Reduced 0.61%	61,996 $2.21 Million
Q2 2017 Aug 14, 2017	BUY	N/A	62,377	62,377 $2.1 Million

Others Institutions Holding PFE

# of Institutions

3,365

Shares Held

3.6B

Call Options Held

102M

Put Options Held

130M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $133B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meridian Investment Counsel Inc., based on Form 13F filings with the SEC.

News

Stay updated on Meridian Investment Counsel Inc. with notifications on news.

Account

Meridian Investment Counsel Inc. Pfizer Inc Transaction History